Integrative analysis of genome-wide loss of heterozygosity and monoallelic expression at nucleotide resolution reveals disrupted pathways in triple-negative breast cancer
Gavin Ha(AstraZeneca (United Kingdom)), Sohrab P. Shah(Memorial Sloan Kettering Cancer Center), Rodrigo Goya(Canada's Michael Smith Genome Sciences Centre), Daniel Lai(Occupational Cancer Research Centre), Jiarui Ding(Broad Institute), Ryan Giuliany(University of British Columbia), Andrew Roth(Canadian Centre for Applied Research in Cancer Control), Marco A. Marra(University of British Columbia), Martin Hirst(University of British Columbia), Samuel Aparício(BC Cancer Agency), Jamie Rosner(University of British Columbia), Karey Shumansky(Canadian Centre for Applied Research in Cancer Control), Ali Bashashati(University of British Columbia), Carlos Caldas(University of Cambridge), Gulisa Turashvili(Harvard University), Arusha Oloumi(University of British Columbia), Suet‐Feung Chin(University of Cambridge)
Cited by 294
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
The <i>GPR54</i> Gene as a Regulator of Puberty
|New England Journal of Medicine|2003|2.5k
The NIH Roadmap Epigenomics Mapping Consortium
|Nature Biotechnology|2010|2k